The evolving role of echocardiography in the assessment of patent foramen ovale in patients with left-side thromboembolism.
patent foramen ovale
transcranial Doppler
transesophageal echocardiography
transthoracic echocardiogram
Journal
Echocardiography (Mount Kisco, N.Y.)
ISSN: 1540-8175
Titre abrégé: Echocardiography
Pays: United States
ID NLM: 8511187
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
revised:
09
02
2021
received:
14
12
2020
accepted:
17
02
2021
pubmed:
20
3
2021
medline:
10
7
2021
entrez:
19
3
2021
Statut:
ppublish
Résumé
Patent foramen ovale (PFO) is the most common congenital cardiac abnormality found approximately in 25% of the adult population The pathophysiological role of paradoxical embolization through the PFO in ischemic stroke is well established. "Self-expanding double disk" and, more recently, suture-based "deviceless" systems are used for PFO closure in the setting of secondary prevention after ischemic stroke likely related to paradoxical embolization. Ultrasound plays a significant role in PFO assessment, indication to treatment, intra-procedural guidance, and follow-up for those undergoing PFO closure. Three different techniques are frequently used for these purposes: transesophageal echocardiography, transthoracic echocardiogram, and transcranial Doppler. In this review, advantages and limits of these techniques are discussed in detail to improve our skills in detection and treatment of this important condition by using ultrasound.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
657-675Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol. 2007;49(7):797-802.
Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17-20.
Homma S, Messé SR, Rundek T, et al. Patent foramen ovale. Nat Rev Dis Prim. 2016;21(2):1-15.
Ozcan Ozdemir A, Tamayo A, Munoz C, Dias B, David SJ. Cryptogenic stroke and patent foramen ovale: Clinical clues to paradoxical embolism. J Neurol Sci. 2008;275(1-2):121-127.
Elgendy AY, Saver JL, Amin Z, et al. Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke. JAMA Neurology; 2020;77(7):878.
Faletra FF, Leo LA, Paiocchi VL, et al. Revisiting anatomy of the interatrial septum and its adjoining atrioventricular junction using noninvasive imaging techniques, J Am Soc Echocardiogr. 2019;32(5):580-592.
van Vonderen JJ, te Pas AB. The first breaths of life: Imaging studies of the human infant during neonatal transition. Paediatric Respiratory Reviews. W.B. Saunders Ltd. 2015;16:143-146.
Bang OY, Lee MJ, Ryoo S, Kim SJ, Kim JW. Patent foramen ovale and stroke-current status. Journal of Stroke. Korean Stroke Society. 2015;17:229-237.
Rigatelli G, Aggio S, Cardaioli P, et al. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm. An Alternative Concurrent Mechanism for Arterial Embolism? JACC Cardiovasc Interv. 2009;2(7):655-662.
Berthet K, Lavergne T, Cohen A, et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke. 2000;31(2):398-403.
Søndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377(11):1033-1042.
Lee PH, Song JK, Kim JS, et al. Cryptogenic stroke and high-risk patent foramen ovale: The DEFENSE-PFO trial. J Am Coll Cardiol. 2018;71(20):2335-2342.
Lethen H, Flachskampf FA, Schneider R, et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol. 1997;80(8):1066-1069.
Pezzini A, Del Zotto E, Magoni M, et al. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke. 2003;34(1):28-33.
Lip PZY, Lip GYH. Patent foramen ovale and migraine attacks: A systematic review. Am J Med. 2014;127(5):411-420.
Torti SR, Billinger M, Schwerzmann M, et al. Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale. Eur Heart J. 2004;25(12):1014-1020.
Rigatelli G, Ronco F. Patent foramen ovale: A comprehensive review for pulmonologists. Current Opinion in Pulmonary Medicine. 2010;16:442-447.
Pristipino C, Germonpre P, Toni D, et al. European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions. EuroIntervention. 2021. [Epub ahead of print].
Tobis JM, Charles A, Silberstein SD, et al. Percutaneous closure of patent foramen ovale in patients with migraine: The PREMIUM trial. J Am Coll Cardiol. 2017;70(22):2766-2774.
Mattle HP, Evers S, Hildick-Smith D, et al. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Eur Heart J. 2016;37(26):2029-2036.
Ben-Assa E, Rengifo-Moreno P, Al-Bawardy R, et al. Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale. JACC Cardiovasc Interv. 2020;13(3):293-302.
Schneider B, Zienkiewicz T, Jansen V, Hofmann T, Noltenius H, Meinertz T. Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am J Cardiol. 1996;77(14):1202-1209.
Mojadidi MK, Bogush N, Caceres JD, Msaouel P, Tobis JM. Diagnostic accuracy of transesophageal echocardiogram for the detection of patent foramen ovale: a meta-analysis. Echocardiography. 2014;31(6):752-758.
Silvestry FE, Cohen MS, Armsby LB, et al. Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen ovale: from the american society of echocardiography and society for cardiac angiography and interventions. J Am Soc Echocardiogr. 2015;28(8):910-958.
Hanley PC, Tajik AJ, Hynes JK, et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: Report of 80 consecutive cases. J Am Coll Cardiol. 1985;6(6):1370-1382.
Saric M, Armour AC, Arnaout MS, et al. Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism. J Am Soc Echocardiogr. 2016;29(1):1-42.
Kerr AJ, Chia KKM, Buck T, et al. Bed tilt as an effort-independent maneuver to improve patent foramen ovale assessment by transthoracic contrast echocardiography. Am J Cardiol. 2001;88(1):94-98.
Takaya Y, Watanabe N, Ikeda M, et al. Importance of abdominal compression valsalva maneuver and microbubble grading in contrast transthoracic echocardiography for detecting patent foramen ovale. J Am Soc Echocardiogr. 2020;33(2):201-206.
Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation. 2005;112(7):1063-1072.
Rodrigues AC, Picard MH, Carbone A, et al. Importance of adequately performed valsalva maneuver to detect patent foramen ovale during transesophageal echocardiography. J Am Soc Echocardiogr. 2013;26(11):1337-1343.
Job FP, Ringelstein EB, Grafen Y, et al. Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. Am J Cardiol. 1994;74(4):381-384.
Woods TD, Patel A. A critical review of patent foramen ovale detection using saline contrast echocardiography: When bubbles lie. J Am Soc Echocardiogr. 2006;19(2):215-222.
Velthuis S, Buscarini E, Gossage JR, Snijder RJ, Mager JJ, Post MC. Clinical implications of pulmonary shunting on saline contrast echocardiography. J Am Soc Echocardiogr, 2015;28(3):255-263.
Tobe J, Bogiatzi C, Munoz C, Tamayo A, Spence JD. Transcranial doppler is complementary to echocardiography for detection and risk stratification of patent foramen ovale. Can J Cardiol. 2016;32(8):986.e9-986.e16.
Holmes M, Rathbone J, Littlewood C, et al. Routine echocardiography in the management of stroke and transient ischaemic attack: A systematic review and economic evaluation. Health Technol Assess (Rockv). 2014;18(16):1-176.
Mojadidi MK, Winoker JS, Roberts SC, Msaouel P, Gevorgyan R, Zolty R. Two-dimensional echocardiography using second harmonic imaging for the diagnosis of intracardiac right-to-left shunt: A meta-analysis of prospective studies. Int J Cardiovasc Imaging. 2014;30(5):911-923.
Mojadidi MK, Roberts SC, Winoker JS, et al. Accuracy of transcranial Doppler for the diagnosis of intracardiac right-to-left shunt: A bivariate meta-analysis of prospective studies. JACC Cardiovasc Imaging. 2014;7(3):236-250.
Katsanos AH, Psaltopoulou T, Sergentanis TN, et al. Transcranial Doppler versus transthoracic echocardiography for the detection of patent foramen ovale in patients with cryptogenic cerebral ischemia: A systematic review and diagnostic test accuracy meta-analysis. Ann Neurol. 2016;79(4):625-635.
Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160-2236.
Furlan AJ, Reisman M, Massaro J, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366(11):991-999.
Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368(12):1092-1100.
Meier B, Kalesan B, Mattle HP, et al. percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368(12):1083-1091.
Saver JL, Carroll JD, Thaler DE, et al. Longterm outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377(11):1022-1032.
Mas J-L, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377(11):1011-1021.
Pristipino C, Sievert H, D’Ascenzo F, et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J. 2019;40(38):3182-3195.
Thaler DE, Ruthazer R, Weimar C, et al. Recurrent stroke predictors differ in medically treated patients with pathogenic vs other PFOs. Neurology. 2014;83(3):221-226.
Turc G, Lee JY, Brochet E, Kim JS, Song JK, Mas JL. atrial septal aneurysm, shunt size, and recurrent stroke risk in patients with patent foramen ovale. J Am Coll Cardiol. 2020;75(18):2312-2320.
Schneider B, Hofmann T, Justen MH, Meinertz T. Chiari’s network: normal anatomic variant or risk factor for arterial embolic events? J Am Coll Cardiol. 1995;26(1):203-210.
Schuchlenz HW, Saurer G, Weihs W, Rehak P. Persisting eustachian valve in adults: Relation to patent foramen ovale and cerebrovascular events. J Am Soc Echocardiogr. 2004;17(3):231-233.
Katsanos AH, Spence JD, Bogiatzi C, et al. Recurrent stroke and patent foramen ovale: A systematic review and meta-analysis. Stroke. 2014;45(11):3352-3359.
Wessler BS, Thaler DE, Ruthazer R, et al. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: Analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging. 2014;7(1):125-131.
Kim YD, Song D, Nam HS, et al. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale. Thromb Haemost. 2015;114(3):614-622.
Abaci A, Unlu S, Alsancak Y, Kaya U, Sezenoz B. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: Meta-analysis of 28,142 patients from 203 studies. Catheter Cardiovasc Interv. 2013;82(7):1123-1138.
Somberg J. Patent foramen ovale closure devices: thoughts from the circulatory device advisory panel. Am J Cardiol. 2007;100:905-906.
Van Den Branden BJ, Luermans JG, Post MC, Plokker HW, Ten Berg JM, Suttorp MJ. The BioSTAR® device versus the CardioSEAL® device in patent foramen ovale closure: Comparison of mid-term efficacy and safety. EuroIntervention. 2010;6(4):498-504.
Saguner AM, Wahl A, Praz F, et al. Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale. Catheter Cardiovasc Interv. 2011;77(5):709-714.
Kimmelstiel C. Device closure of patent foramen ovale-do similar devices achieve similar results?. Catheter Cardiovasc Interv. 2011;77(5):715.
Tande AJ, Knickelbine T, Chavez I, Mooney MR, Poulose A, Harris KM. Transseptal technique of percutaneous PFO closure results in persistent interatrial shunting. Catheter Cardiovasc Interv. 2005;65(2):295-300.
McMahon CJ, El Said HG, Mullins CE. Use of the transseptal puncture in transcatheter closure of long tunnel-type patent foramen ovale. Heart. 2002;88(2):e3.
Geis NA, Pleger ST, Katus HA, Hardt SE. Using the GORE® septal occluder (GSO) in challenging patent foramen ovale (PFO) anatomies. J Interv Cardiol. 2015;28(2):190-197.
Wahl A, Krumsdorf U, Meier B, et al. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol. 2005;45(3):377-380.
de Cillis E, Acquaviva T, D’Alessandro P, Bortone AS. Use of a NobleStitch™ EL Device for PFO Closure. Surg Technol Int. 2018;1(32):219-223.
Gaspardone A, De Marco F, Sgueglia GA, et al. Novel percutaneous suture-mediated patent foramen ovale closure technique: Early results of the NobleStitch EL Italian Registry. EuroIntervention. 2018;14(3):e272-e279.
Gaspardone A, Sgueglia GA, De Santis A, et al. Predictors of residual right-to-left shunt after percutaneous suture-mediated patent fossa ovalis closure. JACC Cardiovasc Interv. 2020;13(18):2112-2120.
Bartel T, Müller S. Contemporary echocardiographic guiding tools for device closure of interatrial communications. Cardiovasc Diagn Ther. 2013;3(1):38-46.
Jone PN, Haak A, Ross M, et al. Congenital and structural heart disease interventions using echocardiography-fluoroscopy fusion imaging. J Am Soc Echocardiogr. 2019;32(12):1495-1504.
Hart RG, Diener HC, Coutts SB, et al. Embolic strokes of undetermined source: The case for a new clinical construct. Lancet Neurol. 2014;13(4):429-438.
Ntaios G, Papavasileiou V, Milionis H, et al. Embolic strokes of undetermined source in the athens stroke registry: A descriptive analysis. Stroke. 2015;46(1):176-181.